EU in talks with Gilead to obtain COVID-19 antiviral remdesivir for the 27 European Union countries

Author: Eamonn Sheridan | Category: News

Some overnight news on the EU discussing with Gilead to reserve doses of remdesivir for EU member states

Discussion may include how to boost production capacity as it seems the US has locked in all available supply of the drug for the three months ahead. 

Some overnight news on the EU discussing with Gilead to reserve doses of remdesivir for EU member states

For bank trade ideas, check out eFX Plus
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose